Durect corporation appoints timothy m. papp as chief financial officer

Cupertino, calif. , july 5, 2022 /prnewswire/ -- durect corporation (nasdaq: drrx), a biopharmaceutical company focused on epigenetic regulation to develop treatments for acute organ injury and chronic liver diseases, today announced the appointment of timothy m.

DRRX Ratings Summary

DRRX Quant Ranking